<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126109">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01964274</url>
  </required_header>
  <id_info>
    <org_study_id>CESARO</org_study_id>
    <nct_id>NCT01964274</nct_id>
  </id_info>
  <brief_title>Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients</brief_title>
  <acronym>CESARO</acronym>
  <official_title>Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective, multicenter observational study the investigators capture the
      perioperative course of peripheral cholinesterase activity. The focus is the perioperative
      inflammation causing postoperative delirium. Therefore we measure the activity of
      Acetylcholine-Esterase and Butyrylcholine-Esterase in whole blood of adults in the
      perioperative context. Early postoperative delirium will be detected by Nu-DESC in the
      Recovery Room or the Postanaesthesia-Care-Unit. The course of the peripheral cholinesterase
      activity will be compared with the incidence of postoperative delirium and other clinical
      dysfunctions.

      We follow up the patients for up to five years regarding Delirum, comorbidities and
      mortality data.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Postoperative Delirium</measure>
    <time_frame>Participants will be followed in the sample period, an exspected average of three days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Postoperative Delirium (measured by Nursing Delirium Screening Scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Organ Dysfunctions</measure>
    <time_frame>Participants will be followed in the sample period, an exspected average of three days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concomitant medication</measure>
    <time_frame>Participants will be followed in the three postoperative days sample period</time_frame>
    <safety_issue>No</safety_issue>
    <description>Concomitant medications from Anticholinergic Drug Scale (ADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain</measure>
    <time_frame>Participants will be followed in the three postoperative days sample period</time_frame>
    <safety_issue>No</safety_issue>
    <description>According to Numeric Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Intensive Care Unit Stay</measure>
    <time_frame>Participants will be followed in the sample period, an exspected average of seven days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Hospital Stay</measure>
    <time_frame>Participants will be followed in the sample period, an exspected average of four weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Mechanical Ventilation</measure>
    <time_frame>Participants will be followed in the sample period, an exspected average of 168 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>Participants will be followed in the sample period, an exspected average of four weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Treatment Data</measure>
    <time_frame>Participations will be followed for the duration of the operation day, an exspected time average of eight hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Operation time, surgery, anaesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Mortality</measure>
    <time_frame>Participants will be followed for the duration of the sample period an exspected average of five years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mortality (measured inhouse-mortality according to the patients´records and  based on the data record according to §21 Krankenhausentgeltgesetz - (KHEntgG))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Delirium</measure>
    <time_frame>Participants will be followed in the sample period, an exspected average of five years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Postoperative Delirium (measured by Diagnosis of Delirium according to the patients´records and based on the data record according to §21 Krankenhausentgeltgesetz -(KHEntgG))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comorbidities</measure>
    <time_frame>Participants will be followed in the sample period, an exspected average of five years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comorbidities based on the data record according to §21 Krankenhausentgeltgesetz - (KHEntgG)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Postoperative Delirium</condition>
  <arm_group>
    <arm_group_label>Surgical patients</arm_group_label>
    <description>Adult male and female patients undergoing surgery</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult, elective surgery patients of both gender
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients with age 18 years and above scheduled for surgery with
             planned stay in Recovery Room or Postanesthesia-Care-Unit

          -  Offered patient information and written informed consent

          -  In-hospital stay for at least 24 hours

        Exclusion Criteria:

          -  Patients with known pseudocholinesterase deficiency

          -  Participation in prospective intervention studies during the study period

          -  Analphabetism

          -  Unability of German and English language use

          -  Anacusis or Hypoacusis with hearing aid device, Amaurosis

          -  Lacking willingness to save and hand out data within the study

          -  Accommodation in an institution due to an official or judicial order

          -  Coworker of the clinic (study center)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia Spies, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claudia Spies, MD Prof.</last_name>
    <phone>+49 30 450 55 10 01</phone>
    <email>claudia.spies@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Spies, MD</last_name>
      <phone>+49 (0) 30 450 55 10 01</phone>
      <email>claudia.spies@charite.de</email>
    </contact>
    <investigator>
      <last_name>Anika Müller</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudia Spies, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic for Anaesthesiology, Intensive Care Medicine, Palliative Medicine and Pain Medicine, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil</name>
      <address>
        <city>Bochum</city>
        <zip>44789</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Zahn, MD</last_name>
      <phone>+49 (0) 234 302 68 25</phone>
      <email>zahn@ains-bergmannsheil.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesiology, Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Hofer, MD, PD</last_name>
      <phone>+49 (0) 6221 56 6350</phone>
      <email>stefan.hofer@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesiology, Klinikum Großhadern of the Ludwig Maximilians University of Munich</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vera von Dossow-Hanfstingl, MD PD</last_name>
      <phone>+49 (0) 89 7095 - 4550</phone>
      <email>vera.dossow@med.uni-muenchen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesiology, Universitätsklinikum Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>York Zausig, MD, PD</last_name>
      <phone>+49 (0) 941 944-7801</phone>
      <email>york.zausig@ukr.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesiology, Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eberhard Barth, MD,  PD</last_name>
      <phone>+49 (0) 731 500 60233</phone>
      <email>erberhardt.barth@uniklinik-ulm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Anaesthesia and Critical Care, Universitätsklinikum Würzburg</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Kranke, MD</last_name>
      <phone>+49 (0) 931 201 300 15</phone>
      <email>kranke_p@klinik.uni-wuerzburg.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 13, 2014</lastchanged_date>
  <firstreceived_date>October 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Claudia Spies</investigator_full_name>
    <investigator_title>Department of Anesthesiology and Intensive Care Medicine CVK/CCM, Charite - Universitätsmedizin Berlin, Germany</investigator_title>
  </responsible_party>
  <keyword>Nursing Delirium Screening Scale,</keyword>
  <keyword>Acetylcholinesterase Activity</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
